Canaccord analyst Caitlin Cronin raised the firm’s price target on Smith & Nephew to $36 from $28 and keeps a Hold rating on the shares. The firm updated its model following Q2 results noting FY25 guidance was unchanged, including continued expectations for 5% underlying growth and proforma trading margins in the range of 19-20%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNN:
- Smith & Nephew Announces Partial Vesting of 2023 Share Awards
- Smith & Nephew: Strong EU MedTech Position and Strategic Initiatives Justify Buy Rating
- Smith & Nephew price target raised to 1,300 GBp from 1,100 GBp at Berenberg
- BlackRock Adjusts Holdings in Smith & Nephew
- Smith & Nephew’s Voting Rights Shift Following BlackRock’s Acquisition